• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Therapy of chronic cardiac insufficiency with ACE inhibitors versus AT1 receptor antagonists. Is there a difference?].

作者信息

Schieffer B, Drexler H

机构信息

Abteilung Kardiologie, Medizinische Hochschule Hannover.

出版信息

Herz. 1997 Dec;22(6):357-60. doi: 10.1007/BF03044289.

DOI:10.1007/BF03044289
PMID:9483441
Abstract
摘要

相似文献

1
[Therapy of chronic cardiac insufficiency with ACE inhibitors versus AT1 receptor antagonists. Is there a difference?].[血管紧张素转换酶抑制剂与血管紧张素Ⅱ1型受体拮抗剂治疗慢性心功能不全的疗效比较。有差异吗？]
Herz. 1997 Dec;22(6):357-60. doi: 10.1007/BF03044289.
2
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.充血性心力衰竭治疗的最新见解：聚焦于血管紧张素转换酶抑制和血管紧张素II拮抗作用。
J Am Coll Cardiol. 1999 Apr;33(5):1163-73. doi: 10.1016/s0735-1097(99)00025-x.
3
[Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].血管紧张素II受体拮抗剂作为治疗慢性心力衰竭新药的疗效——与血管紧张素转换酶抑制剂的比较
Nihon Rinsho. 1999 May;57(5):1148-57.
4
[Chronic cardiac insufficiency. Treatment with angiotensin I converting enzyme inhibitors and angiotensin II receptor antagonists].[慢性心功能不全。血管紧张素I转换酶抑制剂和血管紧张素II受体拮抗剂的治疗]
Presse Med. 2000 Apr 8;29(13):743-8.
5
ACE inhibitors vs ARBs: is one class better for heart failure.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂：哪一类对心力衰竭更有效？
Cleve Clin J Med. 2002 May;69(5):433-8. doi: 10.3949/ccjm.69.5.433.
6
ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.ADEPT：慢性心力衰竭试验中在ACE抑制剂治疗基础上加用AT1受体拮抗剂依普罗沙坦：血流动力学和神经激素效应
Am Heart J. 2001 May;141(5):800-7. doi: 10.1067/mhj.2001.114802.
7
[Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].[肾素 - 血管紧张素系统的病理生理机制及其在心血管疾病中被血管紧张素转换酶抑制剂或血管紧张素II（1型）受体阻滞剂进行的药物修饰]
Z Kardiol. 1997 Apr;86(4):239-50. doi: 10.1007/s003920050055.
8
[Inhibition of renin-angiotensin-aldosterone system in heart failure, or from CONSENSUS to PARADIGM-HF].心力衰竭中肾素-血管紧张素-醛固酮系统的抑制，或从“共识”到“PARADIGM-HF”研究
Vnitr Lek. 2015 May;61(5):470-4.
9
Improvement of cardiac output in patients with severe heart failure by use of ACE-inhibitors combined with the AT1-antagonist eprosartan.
Eur J Heart Fail. 2000 Jun;2(2):183-7. doi: 10.1016/s1388-9842(00)00060-x.
10
Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.血管紧张素转换酶抑制剂和血管紧张素II受体拮抗剂在治疗左心室收缩功能障碍引起的心力衰竭中的应用。
Prog Cardiovasc Dis. 1999 Jan-Feb;41(4):265-300. doi: 10.1053/pcad.1999.0410265.

本文引用的文献

1
Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.
Eur Heart J. 1997 Aug;18(8):1197-9. doi: 10.1093/oxfordjournals.eurheartj.a015425.
2
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).氯沙坦与卡托普利治疗65岁以上心力衰竭患者的随机试验（老年氯沙坦评估研究，ELITE）
Lancet. 1997 Mar 15;349(9054):747-52. doi: 10.1016/s0140-6736(97)01187-2.
3
Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects.
Eur Heart J. 1995 Dec;16 Suppl N:86-91. doi: 10.1093/eurheartj/16.suppl_n.86.
4
Survival after myocardial infarction in rats: captopril versus losartan.
J Am Coll Cardiol. 1996 Mar 1;27(3):714-9. doi: 10.1016/0735-1097(95)00506-4.
5
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.氯沙坦（一种血管紧张素II受体拮抗剂）及其活性代谢物EXP3174在人体内的药代动力学。
Clin Pharmacol Ther. 1995 Dec;58(6):641-9. doi: 10.1016/0009-9236(95)90020-9.
6
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.氯沙坦对志愿者血压、血浆肾素活性及血管紧张素II的影响。
Hypertension. 1993 May;21(5):704-13. doi: 10.1161/01.hyp.21.5.704.
7
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.血管紧张素II拮抗剂氯沙坦对充血性心力衰竭患者的血流动力学及神经激素影响
Circulation. 1993 Oct;88(4 Pt 1):1602-9. doi: 10.1161/01.cir.88.4.1602.
8
Angiotensin II receptors and angiotensin II receptor antagonists.血管紧张素II受体与血管紧张素II受体拮抗剂
Pharmacol Rev. 1993 Jun;45(2):205-51.
9
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?血管紧张素转换酶抑制的抗蛋白尿作用是通过干扰肾素-血管紧张素系统介导的吗？
Kidney Int. 1994 Mar;45(3):861-7. doi: 10.1038/ki.1994.113.
10
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.慢性血管紧张素转换酶抑制与血管紧张素II 1型受体阻断对大鼠心肌梗死后心脏重塑的比较作用
Circulation. 1994 May;89(5):2273-82. doi: 10.1161/01.cir.89.5.2273.